Vertex Prescribed drugs VRTX has outperformed the market over the previous 20 years by 8.34% on an annualized foundation producing a median annual return of 16.94%. At present, Vertex Prescribed drugs has a market capitalization of $96.01 billion.
Shopping for $1000 In VRTX: If an investor had purchased $1000 of VRTX inventory 20 years in the past, it will be price $22,680.80 immediately based mostly on a value of $374.46 for VRTX on the time of writing.
Vertex Prescribed drugs’s Efficiency Over Final 20 Years
Lastly — what is the level of all this? The important thing perception to take from this text is to notice how a lot of a distinction compounded returns could make in your money progress over a time period.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.

